BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 685250)

  • 1. [Determination of the sterol content in fibrinogen as a method of diagnosing the progression of arteriosclerosis].
    Kondrat'eva LG; Vendt VP; Govseeva NN; Solovtsova KM
    Vrach Delo; 1978 Jul; (7):26-8. PubMed ID: 685250
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of hypolipidemic agents on the content of sterol-fibrinogen complexes of the blood in patients with ischemic heart disease].
    Palamarchuk VI; Fedorishko SS
    Vrach Delo; 1989 Jan; (1):39-41. PubMed ID: 2718441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood sterol-fibrinogen complexes in chronic ischemic heart disease].
    Revutskiĭ EL; Palamarchuk VI; Vendt VP; Fedorishko SS
    Vrach Delo; 1979 Sep; (9):43-5. PubMed ID: 494607
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sterol-fibrinogen blood complexes in patients with diabetes mellitus and associated ischemic heart disease].
    Bodnar PN; Donish RM; Buglak NI; Panasiukova OR
    Ter Arkh; 1983; 55(12):78-81. PubMed ID: 6665725
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood fibrinogen-bound sterols in ischemic heart disease].
    Fedorishko SS; Palamarchuk VI
    Vrach Delo; 1979 Nov; (11):20-2. PubMed ID: 524809
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quantitative and qualitative composition of sterol from fibrinogen and erythrocyte membranes in kidney diseases].
    Pyrig LA; Mel'man NIa; Vendt VP; Govseeva NN; Kondrat'eva LG
    Ter Arkh; 1981; 53(12):75-8. PubMed ID: 7336352
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interrelation of diabetes mellitus, atherosclerosis and ischemic heart disease].
    Bodnar PN; Donish RM; Pristupiuk AM
    Ter Arkh; 1984; 56(10):88-92. PubMed ID: 6523367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen-bound sterols in diabetes mellitus patients].
    Bodnar PN
    Vrach Delo; 1983 Apr; (4):57-8. PubMed ID: 6868537
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypercoagulation in fishermen with hypertension, hyperlipidemia and coronary heart disease].
    Cai BL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Jun; 12(2):81-4. PubMed ID: 6489145
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes of certain indicators of blood coagulation in patients with coronary arteriosclerosis and hypertensive disease].
    Pliutto AM
    Lab Delo; 1974; 8(0):465-8. PubMed ID: 4139365
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia.
    Ozerova IN; Jeevan DM; Serdyuk AP; Paramonova IV; Akhmedzhanov NM; Metel'skaya VA; Perova NV
    Bull Exp Biol Med; 2000 Oct; 130(10):983-5. PubMed ID: 11177300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of fibrinogen].
    Yamada S; Izuchi Y; Miyanishi E; Kusunose K
    Nihon Rinsho; 1976; 34 suppl():2380-9. PubMed ID: 792516
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the adhesiveness of human blood platelets--the pathophysiological significance of the adhesiveness of the human blood platelets in alimentary lipemia in coronary sclerosis].
    Takamiya T
    Nihon Naika Gakkai Zasshi; 1969 Nov; 58(11):1170-8. PubMed ID: 5390864
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological half-life of fibrinogen labelled with radioactive iodine I-131 in coronary disease].
    Dordević BS; Bosnjaković V; Baklaja-Jevremović R; Nastić D
    Acta Med Iugosl; 1970; 24(1):7-19. PubMed ID: 5201592
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrinogen serum levels in patients with stable coronary artery disease and acute coronary syndrome].
    Gil M; Zarebiński M; Olszewski R; Adamus J
    Pol Merkur Lekarski; 2000 Aug; 9(50):531-2. PubMed ID: 11081317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins.
    Miettinen TA; Gylling H; Lindbohm N; Miettinen TE; Rajaratnam RA; Relas H;
    J Lab Clin Med; 2003 Feb; 141(2):131-7. PubMed ID: 12577049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simplified method for clinical evaluation of the hexoses of fibrinogen].
    Recalcati P; Pagliano F; Rugarli C
    Haematol Lat; 1967; 10(4):395-407. PubMed ID: 5593509
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinogen and coronary heart disease--what does it mean?
    Oliver MF
    Eur Heart J; 1998 Jan; 19(1):8-9. PubMed ID: 9503169
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperlipemia and hypofibrinolysis in arteriosclerotic disease].
    Prino G; Mantovani M
    Boll Chim Farm; 1967 Feb; 106(2):67-84. PubMed ID: 4893083
    [No Abstract]   [Full Text] [Related]  

  • 20. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
    Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN
    Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.